We are live on
!
Find out more
MLICM
Metropolitan Life Insurance Company (MetLife) Portfolio holdings
AUM
$328M
1-Year Est. Return
9.77%
This Fund
S&P 500
This Quarter
Est. Return
-3.19%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$2.8B
AUM Growth
-$4.56B
(-62%)
Cap. Flow
-$4.1B
Cap. Flow
% of AUM
-146.42%
Top 10 Holdings %
Top 10 Hldgs %
26.34%
Holding
2,829
New
47
Increased
16
Reduced
2,170
Closed
587
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$16.1M |
| 2 |
Sea Limited
SE
|
+$1.24M |
| 3 |
Constellation Energy
CEG
|
+$983K |
| 4 |
AerCap
AER
|
+$414K |
| 5 |
Grab
GRAB
|
+$260K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$259M |
| 2 |
Microsoft
MSFT
|
+$225M |
| 3 |
Amazon
AMZN
|
+$133M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$75.8M |
| 5 |
Tesla
TSLA
|
+$73.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.4% |
| 2 | Healthcare | 12.39% |
| 3 | Financials | 12.03% |
| 4 | Consumer Discretionary | 10.4% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Lifecore Biomedical
LFCR
$181M
| $19.8K | ﹤0.01% |
1,714
-4,107
| -71% | -$45.7K |
|
2102
Janux Therapeutics
JANX
$978M
| $19.8K | ﹤0.01% |
1,382
-2,629
| -66% | -$43K |
|
2103
Personalis
PSNL
$1.54B
| $19.8K | ﹤0.01% |
2,418
-7,440
| -75% | -$77K |
|
2104
Citizens & Northern Corp
CZNC
$466M
| $19.8K | ﹤0.01% |
812
-3,532
| -81% | -$89.5K |
|
2105
Cogent Biosciences
COGT
$6.76B
| $19.8K | ﹤0.01% |
2,639
-8,012
| -75% | -$55.8K |
|
|
KBAL
2106
DELISTED
Kimball International
KBAL
| $19.7K | ﹤0.01% |
2,337
-7,108
| -75% | -$67.5K |
|
2107
Safe Bulkers
SB
$760M
| $19.5K | ﹤0.01% |
+4,096
| New | +$16.7K |
|
2108
Forestar Group
FOR
$1.49B
| $19.5K | ﹤0.01% |
1,097
-3,966
| -78% | -$74.3K |
|
2109
Sight Sciences
SGHT
$456M
| $19.5K | ﹤0.01% |
+1,683
| New | +$25.9K |
|
2110
Tiptree Inc
TIPT
$668M
| $19.4K | ﹤0.01% |
1,511
-1,421
| -48% | -$18.3K |
|
|
FXLV
2111
DELISTED
F45 Training Holdings Inc.
FXLV
| $19.4K | ﹤0.01% |
+1,811
| New | +$23.4K |
|
|
TBCH
2112
Turtle Beach Corp
TBCH
$230M
| $19.3K | ﹤0.01% |
907
-3,595
| -80% | -$75.3K |
|
|
EIGR
2113
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $19.3K | ﹤0.01% |
+78
| New | +$12.3K |
|
2114
South Plains Financial
SPFI
$858M
| $19.3K | ﹤0.01% |
725
-2,216
| -75% | -$62.7K |
|
2115
Regional Management Corp
RM
$297M
| $19.2K | ﹤0.01% |
396
-2,123
| -84% | -$107K |
|
|
CTT
2116
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $19.2K | ﹤0.01% |
2,344
-9,520
| -80% | -$78K |
|
2117
Cullinan Oncology
CGEM
$1.26B
| $19.2K | ﹤0.01% |
1,830
-5,590
| -75% | -$75.5K |
|
|
ESPR
2118
DELISTED
Esperion Therapeutics
ESPR
| $19.1K | ﹤0.01% |
+4,114
| New | +$17.6K |
|
2119
Willdan Group
WLDN
$1.29B
| $19.1K | ﹤0.01% |
622
-2,586
| -81% | -$80.5K |
|
2120
Phathom Pharmaceuticals
PHAT
$742M
| $19.1K | ﹤0.01% |
1,402
-4,540
| -76% | -$73.3K |
|
|
CBAY
2121
DELISTED
Cymabay Therapeutics
CBAY
| $19.1K | ﹤0.01% |
+6,132
| New | +$19.3K |
|
2122
Intapp
INTA
$3.05B
| $19K | ﹤0.01% |
792
-2,420
| -75% | -$52.8K |
|
|
MRSN
2123
DELISTED
Mersana Therapeutics
MRSN
| $19K | ﹤0.01% |
190
-191
| -50% | -$22.3K |
|
|
GNTY
2124
DELISTED
Guaranty Bancshares
GNTY
| $19K | ﹤0.01% |
542
-1,657
| -75% | -$60.2K |
|
2125
VistaGen Therapeutics
VTGN
$11.8M
| $18.8K | ﹤0.01% |
506
-1,640
| -76% | -$71.5K |
|
Similar funds
GWM
KSCM
AFS
BAM
ML
BCM
ECH
PCM
Metropolitan Life Insurance Company (MetLife)'s Q1 2022 Portfolio in Review
As of Q1 2022, Metropolitan Life Insurance Company (MetLife) held 2,829 positions worth $2.8B, down 62% from $7.36B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Metropolitan Life Insurance Company (MetLife) withdrew a net $4.1B in Q1 2022, closing 587 positions and reducing 2,170 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $20.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Metropolitan Life Insurance Company (MetLife) opened a new position in Constellation Energy worth $1.13M.
- Metropolitan Life Insurance Company (MetLife)'s largest Q1 2022 buy was Constellation Energy: 20,148 shares worth $1.13M.
- Metropolitan Life Insurance Company (MetLife) added most to iShares MSCI EAFE ETF in Q1 2022, an estimated $16.1M increase.
- Metropolitan Life Insurance Company (MetLife)'s biggest Q1 2022 reduction was Apple, cutting an estimated $259M.
- Metropolitan Life Insurance Company (MetLife) fully exited iShares Russell 1000 Growth ETF in Q1 2022, selling an estimated $20.5M.
- Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 26% of its $2.8B portfolio in Q1 2022.
- Metropolitan Life Insurance Company (MetLife) opened 47 new positions and closed 587 in Q1 2022.
- Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 62% quarter-over-quarter to $2.8B.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.